Evaluation of the effects of sertraline and Acceptance and Commitment Therapy (ACT) enriched with Compassion Focus Therapy (CFT) on depression, stress, and anxiety
Phase 3
- Conditions
- in addict patients undergoing Methadone Maintenance Therapy.Mood disorder due to known physiological condition with depressive featuresF06.31
- Registration Number
- IRCT20191106045356N1
- Lead Sponsor
- Yazd University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Male
- Target Recruitment
- 60
Inclusion Criteria
duration of methadon use for at least the 6 months
the age range of20_45 years
Exclusion Criteria
Existence of severe mental disorder such as psychosis
Existence of instant psychosis due to psychotropic consumption.
Simultaneous use of NA and similar classes.
Having chronic physical illnesses that affect mood and emotions.
Use of opiates and morphine
Not doing homework at home
Failure to complete the questionnaire in pre-test and post-test
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Depression score. Timepoint: 28 days after intervention. Method of measurement: Examination of the patient and based on a standard questionnaire.
- Secondary Outcome Measures
Name Time Method Depression, stress, and anxiety. Timepoint: Before and after treatment. Method of measurement: DASS-21.